Gain insight on Centene, China’s pharmaceutical sector and more in the latest Market Talks covering the Health Care sector.

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

With tariffs looming and pricing policies shifting, life sciences companies may be on the cusp of “pivotal moment,” according ...

Pfizer is on the brink of a major rebound, transitioning focus to oncology and potential blockbuster drugs after a sharp drop in COVID-related revenues. Pfizer’s stock has plummeted over 50% in the ...

Inaugural 'Innovation Catalyst' event empowers innovators at UConn Health to transform their exciting research ideas into ...

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...

While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Overview of Breast Cancer Therapeutics MarketThe Global Breast Cancer Therapeutics Market is valued at USD 33.83 Billion in ...

Sarepta Therapeutics’ share price has fallen again following the death of a third patient dosed with its gene therapy treatment.

Qatar’s health care sector has undergone a profound transformation over the past decade, evolving into one of the most advanced systems in the GCC. Underpinned by Qatar National Vision (QNV) 2030, the ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...